MedPath

Role of Ginger in patients of Osteoarthritis

Phase 3
Completed
Conditions
Health Condition 1: null- OSTEOARTHRITIS KNEE
Registration Number
CTRI/2011/10/002082
Lead Sponsor
SGRDIMSAR
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

1 Patients of both sexes with symptomatic osteoarthritis of knee who fulfill American college of Rheumatology Criterion for diagnosis of Osteoarthritis

2 Patients having symptomatic Osteoarthritis of knee having knee pain between 40mm and 90 mm on a 100 mm visual analogue scale

Exclusion Criteria

1 Patients with cardiovascular disorders, hypertension and cardiac arrhythmias

2 Pregnant females or those who are planning their pregnancy during the study

3 Patients who have received oral, intramuscular, intraarticular or soft tissue injections of corticosteroids within last four weeks before reporting to OPD

4 Patients diagnosed to have any inflammatory arthritis gout or acute trauma of knee hip or spine

5 Female patients on oral contraceptives

6 Patients with any known hypersensitivity or contraindication to the drugs in study

7 Patients who present with active concomitant gastroduodenal disorders hepatic and renal impairment

8 Patients with any serious/terminal illness

9 Patients with bleeding disorders

10 Patients with diabetes mellitus

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Western Ontario and Macmaster Universities Osteoarthrtitis Index. <br/ ><br>Visual Analogue Scale <br/ ><br>Timepoint: O WEEK, 2 WEEK, 4 WEEK, 6 WEEK, 8 WEEK, 10 WEEK, 12 WEEK
Secondary Outcome Measures
NameTimeMethod
Adverse EventsTimepoint: 0 WEEK ,2 WEEK , 4 WEEK , 6 WEEK, 8 WEEK , 10 WEEK , 12 WEEK
© Copyright 2025. All Rights Reserved by MedPath